The rationale for the subgroup comparison is that when drugs enter an existing therapeutic class, the assumption may be that they are not therapeutically innovative and therefore, the negative predictive value will be higher.
This will help the decision-making process, which is vital in the development of new candidates and the improvement of existing therapeutic antibodies.
Collectively, these findings suggest that systemic MFG-E8 blockade might intensify the antitumor activities of existing therapeutic regimens through coordinated cell-autonomous and immune-mediated mechanisms.
They hope that others will leverage the tools they have developed to set regulatory standards for precision in existing therapeutic applications and expand what applications may be possible.
In vitro experiments have shown that the application of synthetic scaffolds is a promising alternative to existing therapeutic options.
In this review, we discuss the use of synthetic biology to engineer improved yields of existing therapeutic natural products.
Existing therapeutic approaches for the prevention and treatment of atherosclerosis heavily involve statins or PCSK9 antibodies to reduce hypercholesterolemia5,6. Very few, if any, anti-inflammatory agents have been tested for their effectiveness against atherosclerosis.
The increasing emergence of clinical infections caused by methicillin-resistant Staphylococcus aureus (MRSA) challenges existing therapeutic options and highlights the need to develop novel treatment strategies.
In the case of the apicomplexan parasite Toxoplasma gondii, the need to find alternative treatments is imperative because of the poor tolerability and frequent side-effects associated with existing therapeutic strategies.
The existence of endogenous progenitor cells in the adult mammalian brain presents an exciting and attractive alternative to existing therapeutic options for treating neurodegenerative diseases such as Parkinson's disease (PD).
If existing therapeutic interventions are highly efficacious, safe, inexpensive, and firmly entrenched, an active-control design becomes the logical first choice.
